Amylyx Pharmaceuticals, Inc. AMLX
NASDAQ · United States · Health Technology
$29.10-0.18 (-0.61%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.39 | -0.36 | -8.1% | $0 | — | +4.4%$21.85→$22.82 |
| Q1 2026 | 2026-05-07 | -0.37 | -0.34 | -8.8% | — | — | -8.3%$16.06→$14.73 |
| Q4 2025 | 2026-03-03 | -0.30 | -0.34 | +11.8% | — | — | -1.6%$15.30→$15.05 |
| Q3 2025 | 2025-11-06 | -0.37 | -0.43 | +14.0% | — | — | -7.0%$13.24→$12.31 |
| Q4 2024 | 2025-03-04 | -0.55 | -0.59 | +6.8% | — | — | — |
| Q4 2023 | 2024-02-22 | 0.07 | 0.23 | -69.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.